Rekah Pharmaceutical Industry Ltd (REKA) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.037x

Based on the latest financial reports, Rekah Pharmaceutical Industry Ltd (REKA) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA5.27 Million ≈ $14.13K USD) by net assets (ILA144.21 Million ≈ $386.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Rekah Pharmaceutical Industry Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Rekah Pharmaceutical Industry Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Rekah Pharmaceutical Industry Ltd (REKA) financial obligations for a breakdown of total debt and financial obligations.

Rekah Pharmaceutical Industry Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rekah Pharmaceutical Industry Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tourindo Guide Indonesia Pt JK:PGJO	0.979x
Dcon Products Public Company Limited BK:DCON	0.001x
Wellbiotec Co. Ltd. KO:010600	-0.033x
Pelayaran Nelly Dwi Putri Tbk JK:NELY	0.051x
FORCS Co.Ltd KQ:189690	0.034x
Sunfar Computer Co Ltd TWO:6154	-0.006x
Mabion S.A. WAR:MAB	-0.191x
Avonmore Capital & Management Services Limited NSE:AVONMORE	0.003x

Annual Cash Flow Conversion Efficiency for Rekah Pharmaceutical Industry Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Rekah Pharmaceutical Industry Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Rekah Pharmaceutical Industry Ltd (REKA) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA144.21 Million ≈ $386.62K	ILA12.95 Million ≈ $34.72K	0.090x	-45.20%
2024-12-31	ILA161.98 Million ≈ $434.25K	ILA26.54 Million ≈ $71.16K	0.164x	-10.07%
2023-12-31	ILA155.59 Million ≈ $417.12K	ILA28.35 Million ≈ $76.01K	0.182x	-24.28%
2022-12-31	ILA162.08 Million ≈ $434.53K	ILA39.00 Million ≈ $104.56K	0.241x	+96.73%
2021-12-31	ILA173.06 Million ≈ $463.98K	ILA21.17 Million ≈ $56.75K	0.122x	+79.52%
2020-12-31	ILA165.59 Million ≈ $443.94K	ILA11.28 Million ≈ $30.25K	0.068x	-68.81%
2019-12-31	ILA155.22 Million ≈ $416.13K	ILA33.91 Million ≈ $90.92K	0.218x	+90.45%
2018-12-31	ILA150.66 Million ≈ $403.91K	ILA17.28 Million ≈ $46.34K	0.115x	-30.28%
2017-12-31	ILA144.62 Million ≈ $387.73K	ILA23.80 Million ≈ $63.80K	0.165x	-23.69%
2016-12-31	ILA105.86 Million ≈ $283.81K	ILA22.82 Million ≈ $61.19K	0.216x	+359.22%
2015-12-31	ILA123.66 Million ≈ $331.52K	ILA5.81 Million ≈ $15.57K	0.047x	+172.04%
2014-12-31	ILA77.06 Million ≈ $206.59K	ILA1.33 Million ≈ $3.57K	0.017x	-88.28%
2013-12-31	ILA79.51 Million ≈ $213.17K	ILA11.71 Million ≈ $31.38K	0.147x	-26.12%
2012-12-31	ILA71.17 Million ≈ $190.79K	ILA14.18 Million ≈ $38.02K	0.199x	+88.75%
2010-12-31	ILA63.78 Million ≈ $171.00K	ILA6.73 Million ≈ $18.05K	0.106x	-73.98%
2009-12-31	ILA64.15 Million ≈ $171.99K	ILA26.03 Million ≈ $69.78K	0.406x	+261.86%
2008-12-31	ILA58.62 Million ≈ $157.17K	ILA6.57 Million ≈ $17.62K	0.112x	-39.57%
2007-12-31	ILA67.10 Million ≈ $179.88K	ILA12.45 Million ≈ $33.38K	0.186x	+155.46%
2005-12-31	ILA58.85 Million ≈ $157.77K	ILA4.27 Million ≈ $11.46K	0.073x	-80.15%
2004-12-31	ILA48.86 Million ≈ $131.00K	ILA17.87 Million ≈ $47.92K	0.366x	--

About Rekah Pharmaceutical Industry Ltd

TA:REKA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$33.57 Million

ILA12.52 Billion ILA

Market Cap Rank

#23441 Global

#334 in Israel

Share Price

ILA1097.00

Change (1 day)

+2.24%

52-Week Range

ILA1050.00 - ILA1388.00

All Time High

ILA3846.55